Just Biotherapeutics
AcquiredFacts
- HQ
- Seattle
- Sectors
- Biotechnology, Biomanufacturing, Therapeutics
- Founded
- 2014
- Status
- Acquired
- Stage
- Acquired
Is this your organization? Claim it
Archive: Just Biotherapeutics: a startup case study (Fundamentals for Startups)
(https://comotion.uw.edu/) Dean Pettit, former co-founder and chief scientific officer, UW Bioengineering Lecturer and UW PhD graduate coaches bioengineering students on how to work with the latest industry-specific tools they’ll need to navigate career pathways, while keeping an eye on the marketplace. He spoke about an AI/ML application for therapeutic discovery in the biotech industry, and strategies that can empower startups working at the intersection of global health and product development.
Just–Evotec Biologics opens 130,000 sq ft Redmond J.POD to manufacture COVID‑19 antibody therapeutics for U.S. Defense
Just–Evotec Biologics opened a 130,000 sq ft J.POD drug manufacturing facility in Redmond, Washington that uses continuous, autonomous bioprocessing to design, develop and produce antibody therapeutics more efficiently and at lower cost. The plant will manufacture antibodies for the U.S. Department of Defense to potentially treat COVID-19 and supports both small- and large-scale production for biotech customers globally.
Seattle Serial Entrepreneur Ron Berenson’s New UW Spin‑Off DMD Therapeutics Files to Raise $600,000
Ron Berenson has launched a new Seattle biotech startup, DMD Therapeutics, which filed to raise $600,000 with Berenson listed as president; the company is a University of Washington spin-off currently operating in stealth mode. Berenson is a serial entrepreneur who leads several other biotech and medical companies and has a long history in Seattle’s biotech scene.
Questions about Just Biotherapeutics
What is Just Biotherapeutics?
Just Biotherapeutics is an acquired company founded in 2014 and based in Seattle.
What has Just Biotherapeutics been in the news for?
A March 2024 story titled “Archive: Just Biotherapeutics: a startup case study (Fundamentals for Startups)” featured Just Biotherapeutics as a startup case study. GeekWire reported in August 2021 that Just–Evotec Biologics opened a Redmond J.POD to manufacture COVID-19 antibody therapeutics for U.S. Defense.
Who invested in Just Biotherapeutics, and how much has it raised?
Members of Seattle Flow see Just Biotherapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Just Biotherapeutics based?
Just Biotherapeutics is based in Seattle.
When was Just Biotherapeutics founded?
Just Biotherapeutics was founded in 2014.